Zahari Vinarov, Mohammad Abdallah, José A G Agundez, Karel Allegaert, Abdul W Basit, Marlies Braeckmans, Jens Ceulemans, Maura Corsetti, Brendan T Griffin, Michael Grimm, Daniel Keszthelyi, Mirko Koziolek, Christine M Madla, Christophe Matthys, Laura E McCoubrey, Amitava Mitra, Christos Reppas, Jef Stappaerts, Nele Steenackers, Natalie L Trevaskis, Tim Vanuytsel, Maria Vertzoni, Werner Weitschies, Clive Wilson, Patrick Augustijns
The absorption of oral drugs is frequently plagued by significant variability with potentially serious therapeutic consequences. The source of variability can be traced back to interindividual variability in physiology, differences in special populations (age- and disease-dependent), drug and formulation properties, or food-drug interactions. Clinical evidence for the impact of some of these factors on drug pharmacokinetic variability is mounting: e.g. gastric pH and emptying time, small intestinal fluid properties, differences in pediatrics and the elderly, and surgical changes in gastrointestinal anatomy...
July 1, 2021: European Journal of Pharmaceutical Sciences